Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,914 | 5,750 | 35,642 | 27,477 | 34,608 |
| Depreciation Amortization | 12,102 | 5,673 | 13,736 | 6,748 | 2,778 |
| Income taxes - deferred | -3,967 | -2,183 | -8,324 | -4,743 | -4,445 |
| Accounts receivable | -42,701 | -42,515 | -30,832 | -55,325 | -44,312 |
| Accounts payable and accrued liabilities | -3,150 | -1,884 | 2,966 | -3,824 | 2,931 |
| Other Working Capital | -61,634 | -47,717 | -16,404 | -44,593 | -20,457 |
| Other Operating Activity | 54,798 | 49,364 | 53,917 | 87,404 | 55,278 |
| Operating Cash Flow | $-33,638 | $-33,512 | $50,701 | $13,144 | $26,381 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -64 | -58 | -178 | -168 | -168 |
| Net Acquisitions | N/A | N/A | -74,152 | -74,153 | -75,416 |
| Purchase Of Investment | -12,500 | -12,500 | -12,500 | -12,500 | 0 |
| Investing Cash Flow | $-12,564 | $-12,558 | $-86,830 | $-86,821 | $-75,584 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 30,000 | 15,000 | 80,000 | 15,000 | N/A |
| Debt Repayment | -22,500 | -1,250 | -67,236 | -6,000 | -4,000 |
| Common Stock Issued | N/A | N/A | 1,747 | 1,747 | 1,500 |
| Common Stock Repurchased | 0 | 0 | -18,004 | -18,004 | -8,053 |
| Other Financing Activity | -1,265 | -1,104 | -2,716 | -1,341 | -1,341 |
| Financing Cash Flow | $6,235 | $12,646 | $-6,209 | $-8,598 | $-11,894 |
| Beginning Cash Position | 55,321 | 55,321 | 97,659 | 97,659 | 97,659 |
| End Cash Position | 15,354 | 21,897 | 55,321 | 15,384 | 36,562 |
| Net Cash Flow | $-39,967 | $-33,424 | $-42,338 | $-82,275 | $-61,097 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,638 | -33,512 | 50,701 | 13,144 | 26,381 |
| Capital Expenditure | -64 | -58 | -178 | -168 | -168 |
| Free Cash Flow | -33,702 | -33,570 | 50,523 | 12,976 | 26,213 |